- Companies
- Vi Labs
Vi Labs Funding, Investors & Competitors
Vi Labs has raised $147M across 3 funding rounds, most recently a $111M undisclosed-stage round in June 2024.
Last Vi Labs funding round
$111M
Undisclosed stage · Jun 2024
Cumulative funding Vi Labs raised
$147M
across 3 funding rounds
Key investors in Vi Labs
Square Peg Capital
Cerca Partners
Triventures
Wellborn Ventures
General Atlantic
New Era Capital Partners
World Trade Ventures
Savano Capital Partners
About Vi Labs
Vi develops productized artificial intelligence for healthcare and life-sciences enterprises. Its platform combines privacy-safe real-world health signals with applications for patient activation, personalized engagement, operational workflows and performance measurement. The company began with biosensing and a consumer AI fitness coach and has since expanded into enterprise software used across patient and care-team journeys.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Vi Labs Funding History
Vi Labs has raised a total of $147M across 3 funding rounds.
Vi Labs' first fundraising round was a $16M seed round in March 2016. The most recent completed round was a $111M undisclosed-stage round in June 2024.
Vi Labs funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jun 2024 | Undisclosed stage | General Atlantic (lead); Alpha Partners; Savano Capital Partners | $111M | Vi Labs, operating as Vi, is an enterprise artificial intelligence company that helps health organizations, life sciences companies and wellness businesses use data and AI to improve member outcomes and operating returns. In June 2024 the company completed a growth equity round of about $111 million, led by Savano Capital Partners, with participation from General Atlantic, Alpha Partners and Anfield. The company sells to healthcare and life sciences enterprises. The business grew out of the LifeBEAM wearable technology lineage and now sells a platform covering patient activation, engagement and operations. Vi Labs acquired the consumer insights firm Motus in December 2022. |
| Jun 2018 | Series A | Wellborn Ventures; New Era Capital Partners; FGI Capital Partners; Triventures; Square Peg Capital; Joy Ventures; Cerca Partners | $20M | Vi, the company previously known as LifeBEAM, announced a USD 20 million financing on June 21, 2018. New Era Capital Partners participated alongside Square Peg Capital, Cerca Partners, Triventures, Wellborn Ventures, FGI Capital Partners and other investors. At the time, Vi marketed an artificial-intelligence fitness coach delivered through voice-enabled headphones and built on the company's earlier biosensing work. The financing was intended to expand Vi's consumer fitness business, broaden distribution and support the development of its artificial-intelligence software across additional connected audio products and partnerships. Contemporary health-technology and Israeli business coverage support the amount, date, company identity and investor list. The correct database participant is New Era Capital Partners rather than the unrelated New Era Ventures entity. This synopsis is confined to the June 2018 round and does not mix in later convertible financing, subsequent acquisitions or cumulative-funding estimates that do not describe this event. |
| Mar 2016 | Seed | Square Peg Capital (lead); Wellborn Ventures; Atomics 14 Ventures; Triventures; World Trade Ventures; Cerca Partners | $16M | Vi Labs, founded in 2011 by Omri Joffe, develops an AI platform for digital health and fitness, providing personalized audio coaching, machine learning insights from connected devices, and an SDK for fitness brands. The platform processes data to enhance engagement, retention, and health outcomes for users and trainers. Square Peg Capital partnered with Vi Labs in 2016 in a pre-seed round, with additional investors including Atomics 14 Ventures, Cerca Partners, Triventures, Wellborn Ventures, and World Trade Ventures. The company has raised a total of approximately $157.6M to $41.09M across rounds, with later funding including a $20M convertible note in April 2024 and a September 2021 valuation of $225M. Vi Labs serves over 30 million members daily and acquired Motus Consumer Insights in December 2022. |
Who has invested in Vi Labs?
12 investors have backed Vi Labs across its funding rounds, including Square Peg Capital, Cerca Partners, Triventures, Wellborn Ventures, General Atlantic and New Era Capital Partners.
Lead investors include General Atlantic and Square Peg Capital.
Vi Labs Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | Mar 2016 | ||
| 2 | Participant | Mar 2016 | ||
| 2 | Lead | Mar 2016 | ||
| 2 | Participant | Mar 2016 | ||
| 1 | Participant | Jun 2024 | ||
| 1 | Participant | Mar 2016 | ||
| 1 | Participant | Jun 2018 | ||
| 1 | Participant | Jun 2018 | ||
| 1 | Lead | Jun 2024 | ||
| 1 | Participant | Mar 2016 | ||
This data is available for Pro users. Sign up to see all 12 Vi Labs investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialVi Labs Competitors
Vi Labs competitors include listed companies like IQVIA, ICON plc and Privia Health, and private ones like Innovaccer, NantHealth and Unite Us.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $45B | 3.4x | ||
| Publicly listed | $8.3B | $816M | $15B | 2.2x | ||
| Private | $250M | - | $3.5B | 13.8x | ||
| Publicly listed | $2.1B | $44M | $3.1B | 1.1x | ||
| Private | $58M | - | $2B | - | ||
| Private | - | - | $1.6B | - |
Vi Labs Public Comps
Vi Labs is still privately-owned, but its public comps include IDEXX Laboratories, Veeva, Roper Technologies, IQVIA, GE HealthCare, Revvity, Solventum, ICON plc, Pro Medicus and United Imaging.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $4.3B | $1.5B | 12.6x | 11.5x | 35.9x | 32.3x | |||
| $3.2B | $965M | 13.2x | 11.8x | 43.6x | 25.9x | |||
| $7.9B | $3.2B | 7.2x | 6.7x | 17.9x | 17.0x | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.7x | |||
| $21B | $3.7B | 2.2x | 2.1x | 12.0x | 11.6x | |||
| $2.9B | $735M | 6.8x | 6.8x | 26.5x | 21.4x | |||
| $8.3B | $2.5B | 2.4x | 2.4x | 7.9x | 9.9x | |||
| $8.3B | $816M | 2.2x | 2.2x | 22.1x | 13.3x | |||
This data is available for Pro users. Sign up to see all Vi Labs competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Vi Labs
| When was Vi Labs founded? | Vi Labs was founded in 2016. |
| Where is Vi Labs headquartered? | Vi Labs is headquartered in New York City, NY, United States. |
| Is Vi Labs publicly listed? | No, Vi Labs is a private, VC-backed company. |
| How much funding has Vi Labs raised? | Vi Labs has raised $147M across 3 funding rounds. |
| What was Vi Labs' last funding round? | Vi Labs' last funding round was a $111M undisclosed-stage round in June 2024, led by General Atlantic. |
| Who are Vi Labs' investors? | Vi Labs' investors include Wellborn Ventures, Triventures, Square Peg Capital, Cerca Partners, Alpha Partners, Atomics 14 Ventures, New Era Capital Partners, FGI Capital Partners, General Atlantic, World Trade Ventures and 2 others. |
| Which companies are comparable to Vi Labs? | Companies comparable to Vi Labs include IQVIA, ICON plc, Innovaccer, Privia Health, NantHealth and Unite Us. |
See companies similar to Vi Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




